Share
RNA Analysis Market : By Type (Consumables, Instruments, Software and Services), By Application (Clinical Diagnostics, Drug Discovery, Toxicogenomics and Comparative Transcriptomics), And Region - Global Analysis Of Market Size, Share & Trends For 2019-2020 And Forecasts To 2031
The study of the transcriptome, or the entire collection of RNA analysis generated by the genome under specific conditions in a given environment or in a given cell using high-throughput technologies such as microarray analysis, is known as RNA analysis. The technique of RNA sequencing is widely used for determining gene expression levels. It's a versatile method for detecting and characterising gene expression, mutations, gene fusions, and noncoding RNAs, among others.
Global RNA Analysis to surpass USD 14.12 billion by 2031 from USD 4.96 billion in 2021 at a CAGR of 12.4% in the coming years, i.e., 2021-31. The increasing demand for personalised medicine, increasing pharmaceutical and biotechnology R&D expenditure and government funding for omics, and the increasing applications of RNA sequencing in the transcriptomics market are driving the growth of this market. The growing emphasis on biomarker discovery and toxicogenomics, as well as the growing interest in outsourcing services, are expected to offer lucrative growth opportunities for players in the global RNA analysis market
Get More Information - Download Free Sample
Global RNA Analysis market is classified on the basis of Type into Consumables, Instruments, Software and Services. The growing demand for high-quality reagents, as well as the frequent use of media and consumables in transcriptome studies is expected to increase growth of the consumables segment. Furthermore, rising R&D activities in the pharmaceutical industry, rising government investments in life science research, and rising research with integrated omics studies are all contributing to the market for consumables.
Based on application, global RNA Analysis Market is fragmented into Clinical Diagnostics, Drug Discovery, Toxicogenomics and Comparative Transcriptomics. The use of transcriptomics in drug discovery for target identification and validation, identification of efficacy and toxicity biomarkers from biological fluids, and investigation of drug action and toxicity mechanisms is attributed to the growth in this segment. The increased need to study a large number of genes in order to gain a better understanding of gene-to-drug interactions is also expected to drive the use of transcriptomic technologies in drug discovery applications.
Get More Information - Download Free Sample
The market is expected to grow due to rising demand for customised treatment and RNA sequencing applications in transcriptomics. The RNA analysis market is expected to grow significantly over the forecast period due to rapid advancements in the transcriptomics sector. The growing emphasis on biomarker development and toxicogenomic research are likely to provide significant potential opportunities for global RNA analysis market participants.
The growing interest in outsourcing services, as well as the increased emphasis on biomarker discovery and toxicogenomic research, is likely to provide significant growth opportunities for global market participants. Furthermore, rising pharmaceutical and biotechnology R&D expenditures, as well as government funding for omics, are expected to drive market growth.
The high capital investment requirements and data management concerns are expected to limit the growth of this market to some extent. High research investment, high failure rates, and medication delivery challenges are all issues limiting market growth for firms in this industry.
Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis
Global RNA Analysis market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. North America dominates the global market as a result of intense R&D and rising awareness. Rising demand for personalised medicine and increased R&D investment are expected to provide impetus to the growth and approval of transcriptomics technologies.
With unprecedented demand for the study and treatment of COVID-19, the RNA sequencing industry has come to the fore. As the number of COVID-19 cases increases dramatically around the world, so does the demand for the healthcare system. Clinicians and scientists are increasingly using RNA sequencing as a result of increased research activity; both the availability of research funds and the demand for high-throughput technology are expected to grow.
Get More Information - Download Free Sample
REPORT ATTRIBUTE |
DETAILS |
|
Market size value in 2021 |
USD 14.96 billion |
|
Revenue forecast in 2031 |
USD 4.12 billion |
|
Growth Rate |
CAGR of 12.4% from 2021 to 2031 |
|
Base year for estimation |
2020 |
|
Quantitative units |
Revenue in USD million and CAGR from 2021 to 2030 |
|
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
|
Segments covered |
Type, Application and Region |
|
Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
|
Key companies profiled |
CD Genomics, Illumina Inc., Merck Kgaa, Promega Corp., Qiagen NV, Thermo Fisher Scientific Inc., Danaher Corp., Eurofins Scientific, Fluidigm Corp. and Other Prominent Players . |
RNA Analysis market size was estimated at USD 4.96 billion in 2021 and is expected to reach USD 14.12 billion in 2031.
The study of the transcriptome, or the entire collection of RNA analysis generated by the genome under specific conditions in a given environment or in a given cell using high-throughput technologies such as microarray analysis, is known as RNA analysis.
Drug Discovery and consumables accounted for the largest RNA Analysis market share.
Key players: CD Genomics, Illumina Inc., Merck Kgaa, Promega Corp., Qiagen NV are the key players in the RNA Analysis market.
The increasing demand for personalised medicine, increasing pharmaceutical and biotechnology R&D expenditure and government funding for omics, and the increasing applications of RNA sequencing in the transcriptomics market are driving the growth of this market.
Select License Type
Select License Type
FATPOS CLIENT Appriciation DURING THE PROJECT
Working with Fatpos Global, allowed us to take advantage of their knowledge and easy approach, allowing us to collect important data utilizing a variety of techniques. The results were clearly presented and explained, and FG responded to our questions with speed and expertise.
|
Swiss-based global building materials manufacturer |
The analyses and presentations Fatpos Global have produced for us have been of a very high caliber and have allowed us to proactively improve our customer relationship management. They have also done so while maintaining complete anonymity. Without any doubt, we suggest Fatpos Global to you.
|
|
Tech-powered construction company |
We appreciate the team’s punctuality, flexibility in terms of report modification, post report purchase support and pleasant reaction all around. Overall, my experience with this company was nothing but positive, and I couldn't be more grateful for their excellent service. Thank you for all that you do!
|
|
American global management consulting firm |
We are able to concentrate on the topics and implications that are most important to our clients thanks to the adaptability and responsiveness of the team at Fatpos Global. We would highly recommend this company to anyone in need of their services, and I will certainly be using them again in the future.
|
|
Headquartered in Zug, Switzerland, leading supplier of medical and surgical instrument |
To better study our client demographics, develop the ideal product-price architecture, and enhance our target marketing initiatives, we hired Fatpos Global. Every component of the project was completed, and we are very happy with the useful insights and actionable results.
|
|
Kosovan company, A leading organic fertilizers producer |
Thank you for your team's generous assistance, The final report was delivered to me, and I find it to be really helpful. Also, you may be sure that I will get in touch with you if I ever require fresh materials for market research. Gratitude once more.
|
|
German specialty chemicals company based in Cologne, Germany |
